Renal Cell Carcinoma

 

BNC105P w/ Everolimus for Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors

Investigator: Shailender Bhatia, M.D.;   Conditions: Renal Cell Carcinoma;    Status: Recruiting;   Study ID: NCT01034631

Dose-Escalation Study of AGS-16M8F for Advanced Renal Cancer
A Phase 1, Open-label, Multi-center, Dose Escalation Study of the Safety and Pharmacokinetics of AGS-16M8F Monotherapy in Subjects With Advanced Renal Cell Carcinoma

Investigator: Dr John Thompson;   Conditions: Renal Cell Carcinoma;    Status: Recruiting;   Study ID: NCT01114230

PF-05082566 for Advanced Cancer or B-Cell Lymphoma
A Phase 1 Study Of PF-05082566 As A Single Agent In Patients With Advanced Cancer, And In Combination With Rituximab In Patients With Non-Hodgkin's Lymphoma (NHL)

Investigator: Ajay K. Gopal, MD;   Conditions: Non-Hodgkin's Lymphoma (NHL);    Status: Recruiting;   Study ID: NCT01307267